| Product | Product Type | Antibody Family | Clone | Isotype | Application | Expression System | Host | Affinity Tag | Format | Target Name | Species | Reactivity | Catalog # | Size | Price | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Recombinant Proteins | Biosimilars | Abatacept | N/A | Flow cytometry, animal model study | Liquid | CTLA4 | 500001 500002 500003 | 1 mg 5 mg 20 mg | $400 $800 $2200 | |||||||
Antibodies | Biosimilars | Abciximab | Human IgG1 Fab | Flow cytometry, animal model study | Liquid | CD41/CD61 | Human | 500101 500102 500103 | 1 mg 5 mg 20 mg | $250 $750 $1800 | ||||||
Antibodies | Biosimilars | Adalimumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | TNFα | Human | 500301 500302 500303 | 1 mg 5 mg 20 mg | $190 $590 $1800 | ||||||
Antibodies | Biosimilars | Aflibercept | Human IgG1-Fc | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | VEGF | Human | 500401 500402 500403 | 1 mg 5 mg 20 mg | $500 $1200 $3900 | ||||||
Antibodies | Biosimilars | Alemtuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD52 | Human | 500501 500502 500503 | 1 mg 5 mg 20 mg | $250 $750 $1800 | ||||||
Antibodies | Biosimilars | Atezolizuma | Human IgG1 | Flow cytometry, animal model study | Liquid | PD-L1 | Human | 500601 500602 500603 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Avelumab | Human IgG1 | Flow cytometry, animal model study | Liquid | PD-L1 | Human | 500701 500702 500703 | 1 mg 5 mg 20 mg | $190 $750 $1800 | ||||||
Recombinant Proteins | Biosimilars | Belatacep | Human IgG1 | Flow cytometry, animal model study | Liquid | CTLA4 | 500801 500802 500803 | 1 mg 5 mg 20 mg | $400 $800 $1600 | |||||||
Antibodies | Biosimilars | Bevacizumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | VEGF | Human | 500901 500902 500903 | 1 mg 5 mg 20 mg | $125 $400 $960 | ||||||
Antibodies | Biosimilars | Briakinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | IL-12/IL-23 | Human | 501001 501002 501003 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Brolucizumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | VEGF-A | Human | 501101 501102 501103 | 1 mg 5 mg 20 mg | $500 $1200 $3900 | ||||||
Antibodies | Biosimilars | Camrelizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | PD1 | Human | 501201 501202 501203 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Cemiplimab | Human IgG4 | Flow cytometry, animal model study | Liquid | PD1 | Human | 501301 501302 501303 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Cetuximab | Human IgG1 | Flow cytometry, animal model study | Liquid | EGFR | Human | 501401 501402 501403 | 1 mg 5 mg 20 mg | $190 $500 $1390 | ||||||
Antibodies | Biosimilars | Clenoliximab | Human IgG4 | Flow cytometry, animal model study | Liquid | CD4 | Human | 501501 501502 501503 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Cofetuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | PTK7 | Human | 501601 501602 501603 | 1 mg 5 mg 20 mg | $190 $750 $1800 | ||||||
Antibodies | Biosimilars | Daclizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | IL-2 receptor α chain | Human | 501701 501702 501703 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Daratumumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD38 | Human | 501801 501802 501803 | 1 mg 5 mg 20 mg | $175 $590 $1390 | ||||||
Antibodies | Biosimilars | Denosumab | Human IgG2 | Flow cytometry, animal model study | Liquid | CD254 | Human | 501901 501902 501903 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Drozitumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD262 | Human | 502001 502002 502003 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Dupilumab | Human IgG4 | Flow cytometry, animal model study | Liquid | CD124 | Human | 502101 502102 502103 | 1 mg 5 mg 20 mg | $190 $750 $1800 | ||||||
Antibodies | Biosimilars | Durvalumab | Human IgG1 | Flow cytometry, animal model study | Liquid | PD-L1 | Human | 502201 502202 502203 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Efalizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD11a | Human | 502401 502402 502403 | 1 mg 5 mg 20 mg | $250 $750 $1800 | ||||||
Antibodies | Biosimilars | Envafolimab | Human IgG1 | Flow cytometry, animal model study | Liquid | PD-L1 | Human | 502501 502502 502503 | 1 mg 5 mg 20 mg | $250 $650 $2000 | ||||||
Antibodies | Biosimilars | Epratuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD22 | Human | 502601 502602 502603 | 1 mg 5 mg 20 mg | $250 $650 $2000 | ||||||
Recombinant Proteins | Biosimilars | Etanercept | Human IgG1 | Flow cytometry, animal model study | Liquid | TNFR2 | Human | 502701 502702 502703 | 1 mg 5 mg 20 mg | $400 $800 $2200 | ||||||
Antibodies | Biosimilars | Evolocumab | Human IgG2 | Flow cytometry, animal model study | Liquid | PCSK9 | Human | 502801 502802 502803 | 1 mg 5 mg 20 mg | $190 $750 $1800 | ||||||
Antibodies | Biosimilars | Felvizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | RSV | RSV | 502901 502902 502903 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Galiximab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD80 | Human | 503001 503002 503003 | 1 mg 5 mg 20 mg | $250 $750 $2000 | ||||||
Antibodies | Biosimilars | Gemtuzumab | Human IgG4 | Flow cytometry, animal model study | Liquid | CD33 | Human | 503101 503102 503103 | 1 mg 5 mg 20 mg | $250 $650 $1800 | ||||||
Antibodies | Biosimilars | Ifinatamab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD276 | Human | 503201 503202 503203 | 1 mg 5 mg 20 mg | $450 $1200 $3900 | ||||||
Antibodies | Biosimilars | Infliximab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | TNFα | Human | 503301 503302 503303 | 1 mg 5 mg 20 mg | $125 $400 $800 | ||||||
Antibodies | Biosimilars | Ipilimumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CTLA-4 | Human | 503401 503402 503403 | 1 mg 5 mg 20 mg | $190 $750 $2000 | ||||||
Antibodies | Biosimilars | Isatuximab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD38 | Human | 503501 503502 503503 | 1 mg 5 mg 20 mg | $250 $650 $2000 | ||||||
Antibodies | Biosimilars | Matuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | EGFR | Human | 503601 503602 503603 | 1 mg 5 mg 20 mg | $250 $650 $2000 | ||||||
Antibodies | Biosimilars | Minretumomab | Human IgG1 | Flow cytometry, animal model study | Liquid | TAG-72 | Human | 503701 503702 503703 | 1 mg 5 mg 20 mg | $250 $650 $2000 | ||||||
Antibodies | Biosimilars | Mogamulizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CCR4 | Human | 503801 503802 503803 | 1 mg 5 mg 20 mg | $250 $750 $2500 | ||||||
Antibodies | Biosimilars | Muromonab | Human IgG2 | Flow cytometry, animal model study | Liquid | CD3 | Human | 503901 503902 503903 | 1 mg 5 mg 20 mg | $250 $600 $1800 | ||||||
Antibodies | Biosimilars | Nimotuzumab | Human IgG4 | Flow cytometry, animal model study | Liquid | EGFR | Human | 504101 504102 504103 | 1 mg 5 mg 20 mg | $450 $1200 $3900 | ||||||
Antibodies | Biosimilars | Nivolumab | Human IgG4 | Flow cytometry, animal model study | Liquid | PD1 | Human | 504201 504202 504203 | 1 mg 5 mg 20 mg | $190 $590 $1100 | ||||||
Antibodies | Biosimilars | Obinutuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD20 | Human | 504301 504302 504303 | 1 mg 5 mg 20 mg | $250 $750 $1800 | ||||||
Antibodies | Biosimilars | Omalizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | IgE | Human | 504401 504402 504403 | 1 mg 5 mg 20 mg | $175 $590 $1800 | ||||||
Antibodies | Biosimilars | Palivizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | RSV | Human | 504501 504502 504503 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Panitumumab | Human IgG2 | Flow cytometry, animal model study | Liquid | EGFR | Human | 504601 504602 504603 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Pembrolizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | PD1 | Human | 504701 504702 504703 | 1 mg 5 mg 20 mg | $190 $590 $1100 | ||||||
Antibodies | Biosimilars | Pertuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | HER2 | Human | 504801 504802 504803 | 1 mg 5 mg 20 mg | $190 $590 $1800 | ||||||
Antibodies | Biosimilars | Polatuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD76b | Human | 504901 504902 504903 | 1 mg 5 mg 20 mg | $175 $480 $1200 | ||||||
Antibodies | Biosimilars | Ramucirumab | Human IgG1 | Flow cytometry, animal model study | Liquid | VEGFR2 | Human | 505001 505002 505003 | 1 mg 5 mg 20 mg | $190 $590 $1390 | ||||||
Antibodies | Biosimilars | Ranibizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | Vascular endothelial growth factor | Human | 505101 505102 | 2 mg 10 mg | $500 $1250 | ||||||
Antibodies | Biosimilars | Relatlimab | Human IgG4 | Flow cytometry, animal model study | Liquid | CD223 | Human | 505201 505202 505203 | 1 mg 5 mg 20 mg | $175 $590 $1800 | ||||||
Antibodies | Biosimilars | Rituximab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD20 | Human | 505301 505302 505303 | 1 mg 5 mg 20 mg | $190 $590 $1800 | ||||||
Antibodies | Biosimilars | Rovalpituzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | DLL3 | Human | 505401 505402 505403 | 1 mg 5 mg 20 mg | $190 $550 $1390 | ||||||
Antibodies | Biosimilars | Sacituzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | TROP2 | Human | 505501 505502 505503 | 1 mg 5 mg 20 mg | $175 $550 $1100 | ||||||
Antibodies | Biosimilars | Secukinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | IL-17A | Human | 505601 505602 505603 | 1 mg 5 mg 20 mg | $175 $590 $1390 | ||||||
Antibodies | Biosimilars | Semaglutide | NA | Flow cytometry, animal model study | Liquid | GLP-1 receptor | Human | 505701 505702 505703 | 1 mg 5 mg 20 mg | $190 $480 $1100 | ||||||
Antibodies | Biosimilars | Spartalizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | PD1 | Human | 505801 505802 505803 | 1 mg 5 mg 20 mg | $220 $650 $2000 | ||||||
Antibodies | Biosimilars | Tanezumab | Human IgG2 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | NGF | Human | 505901 505902 505903 | 1 mg 5 mg 20 mg | $190 $480 $1200 | ||||||
Antibodies | Biosimilars | Tocilizumab | Human IgG1 | Flow cytometry, animal model study | Liquid | IL-6R | Human | 506001 506002 506003 | 1 mg 5 mg 20 mg | $190 $590 $1800 | ||||||
Antibodies | Biosimilars | Trastuzumab | Human IgG1 | Flow cytometry, animal model study | Liquid | HER2 | Human | 506101 506102 506103 | 1 mg 5 mg 20 mg | $175 $590 $1500 | ||||||
Antibodies | Biosimilars | Trastuzumab | Human IgG1, L234A L235A P329G (LALAPG) | Flow cytometry, animal model study | Liquid | HER2 | Human | 506201 | 1 mg | $650 | ||||||
Antibodies | Biosimilars | Trastuzumab | Human IgG1, N297A | Flow cytometry, animal model study | Liquid | HER2 | Human | 506301 | 1 mg | $650 | ||||||
Antibodies | Biosimilars | Tremelimumab | Human IgG2 | Flow cytometry, animal model study | Liquid | CTLA4 | Human | 506401 506402 506403 | 1 mg 5 mg 20 mg | $175 $550 $1100 | ||||||
Antibodies | Biosimilars | Tusamitamab | Human IgG1 | Flow cytometry, animal model study | Liquid | CD66e | Human | 506501 506502 506503 | 1 mg 5 mg 20 mg | $190 $590 $1500 | ||||||
Antibodies | Biosimilars | Ustekinumab | Human IgG1 | Neutralization, Intracellular Flow cytometry, animal model study | Liquid | IL-12/IL-23 | Human | 506601 506602 506603 | 1 mg 5 mg 20 mg | $190 $590 $2000 | ||||||
Antibodies | Biosimilars | Zolbetuximab | Human IgG1 | Flow cytometry, animal model study | Liquid | CLDN18.2 | Human | 506701 506702 506703 | 1 mg 5 mg 20 mg | $190 $590 $1800 | ||||||
Antibodies | Biosimilars | Eculizumab | Human IgG4 | Flow cytometry, animal model study | Liquid | C5 | Human | 506801 506802 506803 | 1 mg 5 mg 20 mg | $200 $650 $2200 |